An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

By Zheng Zhou, L. Sehn, A. Rademaker, L. Gordon, A. LaCasce, Allison L. Crosby-Thompson, A. Vanderplas, A. Zelenetz, G. Abel, M. Rodriguez and 9 more. Blood, 2014

886 citations recorded by the source corpus.

Subfields: Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/5835aee9687d11160fd503ad0ecb876e36789aca